Abnormal cerebral neuronal migration in a rat model of intrauterine growth retardation induced by synthetic thromboxane A(2)

• Published in: Early human development Vol. 58; no. 2; p. 91
• Main Authors: Sasaki, J, Fukami, E, Mimura, S, Hayakawa, M, Kitoh, J, Watanabe, K
• Format: Journal Article
• Language: English
• Published: Ireland 01.05.2000
• Subjects: Animals; Animals, Newborn; Brain - pathology; Cell Movement; Disease Models, Animal; Female; Fetal Growth Retardation - chemically induced; Fetal Growth Retardation - pathology; Neurons - physiology; Pregnancy; Rats; Rats, Sprague-Dawley; Thromboxane A2
• ISSN: 0378-3782; 1872-6232
• DOI: 10.1016/S0378-3782(00)00069-4

Many reports have associated intrauterine growth retardation (IUGR) with adverse neurological outcome, but the underlying pathology is imperfectly understood. We have developed a new rat model of IUGR using maternal administration of synthetic thromboxane A(2) (STA(2)). In the present study, the effect of this insult on neuronal migration in the rat cerebral cortex was examined. Bromodeoxyuridine (BrdU), a time-specific cell marker was administered intraperitoneally to the mothers on embryonic day (E) 19. At postnatal day (P) 3, P4, P5, and P6, pups were terminally anesthetized and brains were removed. BrdU-labeled cells were detected immunohistochemically and counted in cerebrum, which was divided into the cortical plate (CP), the intermediate zone, and the subventricular/ventricular zone (SVZ+VZ). Numbers of labeled cells in the three areas over time were compared between IUGR and control animals. Numbers of labeled cells in SVZ+VZ were significantly greater in IUGR than in controls at P3, 5, and 6 (P<0.05). In contrast, labeled cells in the CP were significantly less abundant in IUGR animals than in controls at P3, 4, and 6 (P<0.05). We concluded that neuronal migration was delayed in IUGR rats.